Drugs / BI 473494
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03195088 | Jul → Nov 2017 | — | Boehringer Ingelheim | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 473494 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03195088 ↗ |
| Route | Subcutaneous | “via subcutaneous injection” NCT03195088 ↗ |